Role of Glutathione in Cancer Progression and Chemoresistance

Methods in Enzymology , Vol

Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137 · see citing works

Free radicals and antioxidants in normal physiological functions and human disease

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works

Free Radicals in the Physiological Control of Cell Function

Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855 · see citing works

GLUTATHIONE

Meister, A., & Anderson, M. E. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.003431 · Cited by 5,694 · see citing works

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587 · see citing works

An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements

Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · see citing works

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655 · see citing works

Regulation of glutathione synthesis

Lu, S. C.-L. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.005 · Cited by 2,131 · see citing works

The importance of glutathione in human disease

Townsend, D. M., Tew, K. D., & Tapiero, H. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00043-x · Cited by 2,009 · see citing works

Antioxidant and redox regulation of gene transcription

Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,996 · see citing works

Glutathione and its role in cellular functions

Sies, H. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00177-x · Cited by 1,735 · see citing works

Radical causes of cancer

Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · see citing works

A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure

Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682 · see citing works

The p38 signal transduction pathway Activation and function

Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571 · see citing works

Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions

Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266 · see citing works

Heme oxygenase-1: unleashing the protective properties of heme

Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166 · see citing works

Regulation of JNK signaling by GSTp

Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1321 · Cited by 1,105 · see citing works

Glutathione in Cancer Biology and Therapy

Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041 · see citing works

The role of glutathione in cancer

Balendiran, G. K., Dabur, R., & Fraser, D. A. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 929 · see citing works

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., & Anderson, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3070 · Cited by 926 · see citing works

Reactive Oxygen Species: A Breath of Life or Death?

Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 908 · see citing works

Glutathione deficiency produced by inhibition of its synthesis, and its reversal; Applications in research and therapy

Meister, A. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90076-x · Cited by 906 · see citing works

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

Hayes, J. D., & McMahon, M. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.008 · Cited by 870 · see citing works

Regulation of hepatic glutathione synthesis: current concepts and controversies

Lu, S. C.-L. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1169 · Cited by 857 · see citing works

Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells.

Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., & Cowan, K. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66748-1 · Cited by 790 · see citing works

Cancer cell killing via ROS: To increase or decrease, that is the question

Wang, J., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7067 · Cited by 790 · see citing works

Cancer related mutations in <i>NRF2</i> impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728 · see citing works

Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis.

Griffith, O. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33504-x · Cited by 701 · see citing works

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism

Ren, D., Villeneuve, N. F., Jiang, T., Wu, T., Lau, A., Toppin, H. A., & Zhang, D. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014275108 · Cited by 673 · see citing works

Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth

Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 630 · see citing works

Repression of gene expression by oxidative stress

Morel, Y., & Barouki, R. (1999) · Biochemical Journal · doi:10.1042/bj3420481 · Cited by 543 · see citing works

Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System

Dai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540 · see citing works

Mitochondrion as a Novel Target of Anticancer Chemotherapy

Costantini, P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1042 · Cited by 532 · see citing works

Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury

Otterbein, L. E., Zuckerbraun, B. S., Haga, M., Liu, F., Song, R., Usheva, A., Stachulak, C., Bodyak, N. D., Smith, R. N., Csizmadia, E., et al. (2003) · Nature Medicine · doi:10.1038/nm817 · Cited by 527 · see citing works

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526 · see citing works

Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer

Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M. P., & Hirohashi, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.082 · Cited by 470 · see citing works

Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities

Wondrak, G. T. (2009) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2009.2541 · Cited by 462 · see citing works

[1] Glutathione metabolism

Meister, A. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)51106-7 · Cited by 429 · see citing works

Heme Oxygenase-1 in Tumors: Is It a False Friend?

Józkowicz, A., Waś, H., & Dulak, J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 381 · see citing works

Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells

Cen, D., Brayton, D. F., Shahandeh, B., Meyskens, F. L., & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 336 · see citing works

Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor-E2–related factor-2 transcriptional pathway

Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G. L., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21831 · Cited by 315 · see citing works

Role of Cysteine Residues in Regulation of p53 Function

Rainwater, R., Parks, D., Anderson, M. E., Tegtmeyer, P., & Mann, K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3892 · Cited by 305 · see citing works

Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

Cowan, K. H., Batist, G., Tulpule, A., Sinha, B. K., & Myers, C. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9328 · Cited by 293 · see citing works

High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer

Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286 · see citing works

Expression of γ-glutamyltransferase in cancer cells and its significance in drug resistance

Alfonso Pompella, C., Tata, V. D., Paolicchi, A., & Zunino, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.005 · Cited by 280 · see citing works

Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment

Berberat, P. O., Dambrauskas, Ž., Gulbinas, A., Giese, T., Giese, N. A., Künzli, B. M., Autschbach, F., Meuer, S., Büchler, M. W., & Frieß, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2159 · Cited by 263 · see citing works

Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration

Huang, Z., Chen, C., Zeng, Z., Yang, H., Oh, J., Chen, L., & Lu, S. C.-L. (2000) · The FASEB Journal · doi:10.1096/fj.00-0445fje · Cited by 244 · see citing works

Glutathione and related enzymes in multidrug resistance

O’Brien, M. L., & Tew, K. D. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00051-2 · Cited by 241 · see citing works

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects

Lewis, A. D., Hayes, J. D., & Wolf, C. R. (1988) · Carcinogenesis · doi:10.1093/carcin/9.7.1283 · Cited by 223 · see citing works

In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor.

Fang, J. Q., Sawa, T., Akaike, T., Akuta, T., Sahoo, S. K., Greish, K. F., Hamada, A., & Maeda, H. (2003) · PubMed · Cited by 221 · see citing works

Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase.

Tate, S. S., & Meister, A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4806 · Cited by 219 · see citing works

Adaptation to Oxidative Stress, Chemoresistance, and Cell Survival

Landriscina, M., Maddalena, F., Laudiero, G., & Esposito, F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2692 · Cited by 215 · see citing works

Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes

Rushworth, S. A., MacEwan, D. J., & O’Connell, M. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6730 · Cited by 215 · see citing works

Small Maf (MafG and MafK) Proteins Negatively Regulate Antioxidant Response Element-mediated Expression and Antioxidant Induction of the NAD(P)H:Quinone Oxidoreductase1 Gene

Dhakshinamoorthy, S., & Jaiswal, A. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003531200 · Cited by 205 · see citing works

Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer

Montero, A. J., & Jassem, J. (2011) · Drugs · doi:10.2165/11592590-000000000-00000 · Cited by 194 · see citing works

A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells

Friesen, C., Kiess, Y., & Debatin, K. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401431 · Cited by 194 · see citing works

Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution

Maines, M. D., & Abrahamsson, P. (1996) · Urology · doi:10.1016/s0090-4295(96)00010-6 · Cited by 186 · see citing works

Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity

Nowis, D., Legat, M., Grzela, T., Niderla, J., Wilczek, E., Wilczynski, G. M., Głodkowska‐Mrówka, E., Mrówka, P., Issat, T., Dulak, J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209378 · Cited by 185 · see citing works

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

Maeda, H., Hori, S., Ohizumi, H., Segawa, T., Kakehi, Y., Ogawa, O., & Kakizuka, A. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401389 · Cited by 183 · see citing works

Overexpression of the Heme Oxygenase Gene in Renal Cell Carcinoma

Goodman, A. I., CHOUDHURY, M. S., da Silva, J.-L., Schwartzman, M. L., & Abraham, N. G. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44069 · Cited by 182 · see citing works

Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.

Messina, J. P., & Lawrence, D. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1974 · Cited by 167 · see citing works

γ-Glutamyltransferase, redox regulation and cancer drug resistance

Pompella, A., Corti, A., Paolicchi, A., et al. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.004 · Cited by 167 · see citing works

Hydrogen peroxide produced during γ‐glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells

BELLO, B. D., Paolicchi, A., Comporti, M., et al. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.69 · Cited by 166 · see citing works

Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan

Bailey, H. H., Ripple, G. H., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D. B., Feierabend, C., Mahvi, D. A., Schink, J. C., Pomplun, M. L., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164 · see citing works

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

O'Dwyer, P. J., Hamilton, T. C., LaCreta, F. P., Gallo, J. M., Kilpatrick, D. L., Halbherr, T., Brennan, J. M., Bookman, M. A., Hoffman, J., Young, R. C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.249 · Cited by 162 · see citing works

Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin

Fang, J. Q., Sawa, T., Akaike, T., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11644 · Cited by 156 · see citing works

On the discovery of glutathione

Meister, A. (1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90148-x · Cited by 137 · see citing works

Glutathione and glutathione-dependent enzymes in cancer drug resistance

McLellan, L. I., & Wolf, C. R. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0083 · Cited by 133 · see citing works

Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells

Carretero, J., Obrador, E., Anasagasti, M. J., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006725226078 · Cited by 124 · see citing works

Glutathione and glutathione analogues; Therapeutic potentials

Wu, J. H., & Batist, G. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.016 · Cited by 123 · see citing works

Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells

Saunders, D. E., Lawrence, W. D., CHRISTENSEN, C. W., Wappler, N. L., Ruan, H., & Deppe, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970117)70:2 · Cited by 121 · see citing works

Inhibition of AP-1 DNA Binding by Nitric Oxide Involving Conserved Cysteine Residues in Jun and Fos

Nikitovic, D., Holmgren, A., & Spyrou, G. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7930 · Cited by 119 · see citing works

Glutathione synthetase. Purification from rat kidney and mapping of the substrate binding sites.

Oppenheimer, L., Wellner, V. P., Griffith, O. W., et al. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50577-9 · Cited by 116 · see citing works

Clinical studies of reversal of drug resistance based on glutathione

Calvert, P. M., Yao, K.-S., Hamilton, T. C., & O'Dwyer, P. J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00008-8 · Cited by 112 · see citing works

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

Montero, A. J., Diaz-Montero, C. M., Deutsch, Y. E., Hurley, J. E., Koniaris, L. G., Rumboldt, T., Yasir, S., Jorda, M., Garret-Mayer, E., Avisar, E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1889-0 · Cited by 112 · see citing works

Experimental therapeutics: targeting the redox Achilles heel of cancer.

Cabello, C. M., Bair, W. B., & Wondrak, G. T. (2007) · PubMed · Cited by 110 · see citing works

Depletion of Glutathione by Buthionine Sulfoximine Is Cytotoxic for Human Neuroblastoma Cell Lines via Apoptosis

Anderson, C. P., Tsai, J. M., Meek, W. E., et al. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4303 · Cited by 109 · see citing works

Design, Synthesis, and Evaluation of γ-Phosphono Diester Analogues of Glutamate as Highly Potent Inhibitors and Active Site Probes of γ-Glutamyl Transpeptidase

Han, L., Hiratake, J., Kamiyama, A., et al. (2007) · Biochemistry · doi:10.1021/bi061890j · Cited by 107 · see citing works

Regulation of Ribonucleotide Reductase

Holmgren, A. (1981) · Current topics in cellular regulation · doi:10.1016/b978-0-12-152819-5.50019-1 · Cited by 106 · see citing works

Erratum: Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Joseph, B., Marchetti, P., Formstecher, P., Kroemer, G., Lewensohn, R., & Zhivotovsky, B. (2017) · Oncogene · doi:10.1038/onc.2017.78 · Cited by 105 · see citing works

Extracellular glutathione and γ-glutamyl transpeptidase prevent H2O2-induced injury by 2,3-dimethoxy-1,4-naphthoquinone

Shi, M., Gozal, E., Choy, H. A., et al. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90125-e · Cited by 100 · see citing works

Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment

Joseph, B., Marchetti, P., Formstecher, P., Kroemer, G., Lewensohn, R., & Zhivotovsky, B. (2002) · Oncogene · doi:10.1038/sj.onc.1205018 · Cited by 99 · see citing works

Acceleration of Glutathione Efflux and Inhibition of γ-Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity

Benlloch, M., Ortega, Á., Ferrer, P., Segarra, R., Obrador, E., Asensi, M. A., Carretero, J., & Estrela, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408531200 · Cited by 92 · see citing works

Human ovarian tumors express gamma-glutamyl transpeptidase.

Hanigan, M. H., Frierson, H. F., Brown, J. E., Lovell, M. A., & Taylor, P. T. (1994) · PubMed · Cited by 90 · see citing works

γ-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver

Obrador, E., Carretero, J., Ortega, Á., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30277 · Cited by 87 · see citing works

Motexafin Gadolinium and Zinc Induce Oxidative Stress Responses and Apoptosis in B-Cell Lymphoma Lines

Lecane, P. S., Karaman, M. W., Sirisawad, M., Naumovski, L., Miller, R. A., Hacia, J. G., & Magda, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2754 · Cited by 75 · see citing works

Buthionine Sulfoximine Enhancement of Arsenic Trioxide-Induced Apoptosis in Leukemia and Lymphoma Cells Is Mediated via Activation of c-Jun NH2-Terminal Kinase and Up-regulation of Death Receptors

Chen, D., Chan, R., Waxman, S., & Jing, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0409 · Cited by 71 · see citing works

Loss of suppression of GSH synthesis at low cell density in primary cultures of rat hepatocytes

Lu, S. C.-L., & Ge, J. L. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.6.c1181 · Cited by 69 · see citing works

Strategies for Prolonged Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Fidias, P. M., & Novello, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7074 · Cited by 68 · see citing works

Pyrrolidine Dithiocarbamate Prevents p53 Activation and Promotes p53 Cysteine Residue Oxidation

Wu, H., & Momand, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18898 · Cited by 68 · see citing works

Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells

Zhan, L., Zhang, H., Zhang, Q., Woods, C. G., Chen, Y., Xue, P., Dong, J., Tokar, E. J., Xu, Y., Hou, Y., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.041 · Cited by 67 · see citing works

Surgical trauma decreases glutathione synthetic capacity in human skeletal muscle tissue

Luo, J., Hammarqvist, F., Andersson, K., & Wernerman, J. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.2.e359 · Cited by 67 · see citing works

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome

Raza, A., Galili, N., Smith, S. E., Godwin, J. E., Lancet, J. E., Melchert, M., Jones, M., Keck, J., Meng, L., Brown, G. L., et al. (2009) · Blood · doi:10.1182/blood-2009-01-176032 · Cited by 65 · see citing works

Expression of γ-glutamylcysteine synthetase (γ-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs

Oguri, T., Fujiwara, Y., Isobe, T., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.181 · Cited by 59 · see citing works

Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells

Corti, A., Duarte, T. L., Giommarelli, C., Tata, V. D., Paolicchi, A., Jones, G. D. D., & Alfonso Pompella, C. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.05.010 · Cited by 59 · see citing works

Frequent coexpression of MRP/GS-X pump and γ-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues

Kuo, M. T., Bao, J., Furuichi, M., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00494-2 · Cited by 57 · see citing works

Detection of a unique γ-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: A new candidate for early diagnosis of hepatocellular carcinoma

Tsutsumi, M., Sakamuro, D., Takada, A., et al. (1996) · Hepatology · doi:10.1002/hep.510230524 · Cited by 54 · see citing works

Glutathione depletion up‐regulates Bcl‐2 in BSO‐resistant cells

D'ALESSIO, M., Cerella, C., Amici, C., Pesce, C. D., Coppola, S., Fanelli, C., Nicola, M. D., Cristofanon, S., Clavarino, G., Bergamaschi, A., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1813fje · Cited by 53 · see citing works

Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.

Mulcahy, R., Untawale, S., & Gipp, J. J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09832-3 · Cited by 51 · see citing works

Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs

Chakrapani, H., Ravi Charan Reddy, K., Maciag, A. E., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.063 · Cited by 50 · see citing works

Tumoricidal Activity of Endothelial Cells

Carretero, J., Obrador, E., Esteve, J. M., Ortega, Á., Pellicer, J. A., Vera-Sempere, F. J., & Estrela, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101148200 · Cited by 48 · see citing works

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome

Raza, A., Galili, N., Smith, S. E., Godwin, J. E., Boccia, R. V., Myint, H., Mahadevan, D., Mulford, D. A., Rarick, M. U., Brown, G. L., et al. (2011) · Cancer · doi:10.1002/cncr.26469 · Cited by 46 · see citing works

Role of PKC-δ activity in glutathione-depleted neuroblastoma cells

Domenicotti, C., Marengo, B., Verzola, D., Garibotto, G., Traverso, N., Patriarca, S., Maloberti, G., Cottalasso, D., Poli, G., Passalacqua, M., et al. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00332-0 · Cited by 46 · see citing works

Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1

Furfaro, A. L., Macay, J. R. Z., Marengo, B., Nitti, M., Parodi, A., Fenoglio, D., Marinari, U. M., Pronzato, M. A., Domenicotti, C., & Traverso, N. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.007 · Cited by 42 · see citing works

Phase II Study of Carboplatin and Pemetrexed for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer

Matulonis, U. A., Horowitz, N. S., Campos, S. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0282 · Cited by 42 · see citing works

p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment

Marengo, B., Ricciarelli, R., Ciucis, C. D. D., Furfaro, A., Colla, R., Canepa, E., Traverso, N., Marinari, U., Pronzato, M., & Domenicotti, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.118 · Cited by 40 · see citing works

Enhancement of pulmonary metastasis formation and ?-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro

Prezioso, J. A., Wang, N., Duty, L., et al. (1993) · Clinical & Experimental Metastasis · doi:10.1007/bf00121169 · Cited by 38 · see citing works

NOV-002, a mimetic of glutathione disulfide

Townsend, D. M., Pazoles, C. J., & Tew, K. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.1075 · Cited by 37 · see citing works

Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma

Hochwald, S. N., Rose, D. M., Brennan, M. F., et al. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303579 · Cited by 37 · see citing works

γ -Glutamyltranspeptidase activity in human breast lesions: An unfavourable prognostic sign

Bard, S., Noël, P., Chauvin, F., et al. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.107 · Cited by 34 · see citing works

Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma

Hernández‐Breijo, B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i34.3899 · Cited by 33 · see citing works

PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage

Marengo, B., Ciucis, C. D. D., Ricciarelli, R., Passalacqua, M., Nitti, M., Zingg, J.-M., Marinari, U., Pronzato, M., & Domenicotti, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014661 · Cited by 31 · see citing works

Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice

Roomi, M. W., Gaal, K. K., Yuan, Q. X., et al. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.02.006 · Cited by 31 · see citing works

Development and Evaluation of a Boronate Inhibitor of γ-Glutamyl Transpeptidase

London, R. E., & Gabel, S. A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2169 · Cited by 31 · see citing works

Potentiation of Treosulfan Toxicity by the Glutathione-Depleting Agent Buthionine Sulfoximine in Human Malignant Glioma Cells

Reber, U., Wüllner, U., Trepel, M., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00480-2 · Cited by 28 · see citing works

Biological and enzymatic features of human melanoma clones with different invasive potential

Supino, R., Mapelli, E., Sanfilippo, O., et al. (1992) · Melanoma Research · doi:10.1097/00008390-199212000-00012 · Cited by 28 · see citing works

Pharmacology of a mimetic of glutathione disulfide, NOV-002

Townsend, D. M., & Tew, K. D. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.08.019 · Cited by 27 · see citing works

Structure-Based Identification of Novel Human γ-Glutamylcysteine Synthetase Inhibitors

Hamilton, D., Wu, J. H., & Batist, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.024778 · Cited by 25 · see citing works

γ-Glutamyl transpeptidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias

Täger, M., Ittenson, A., Franke, A., et al. (1995) · Annals of Hematology · doi:10.1007/bf01784042 · Cited by 24 · see citing works

Identification and Characterization of Novel Nrf2 Inducers Designed to Target the Intervening Region of Keap1

Wu, J. H., Miao, W., Hu, L. G., & Batist, G. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00955.x · Cited by 22 · see citing works

DNA oxidative damage of neoplastic rat liver lesions

Domenicotti (2010) · Oncology Reports · doi:10.3892/or_00000756 · Cited by 17 · see citing works

Glutathione protects against hypoxic/hypoglycemic decreases in 2-deoxyglucose uptake and presynaptic spikes in hippocampal slices

Shibata, S., Tominaga, K., & Watanabe, S. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00727-o · Cited by 15 · see citing works

TLK-199 (Telik).

Hamilton, D., & Batist, G. (2005) · PubMed · Cited by 11 · see citing works

GSH loss per se does not affect neuroblastoma survival and is not genotoxic

Marengo, B., Balbis, E., Patriarca, S., et al. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.1.121 · Cited by 8 · see citing works

?-Glutamyl transpeptidase - cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias

T�ger, M., Ittenson, A., Franke, A., et al. (1995) · Annals of Hematology · doi:10.1007/s002770050062 · Cited by 2 · see citing works

Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer

Moog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2

Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy

Niu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168 · see citing works

Role of Glutathione in Cancer: From Mechanisms to Therapies

Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880 · see citing works

Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy

Lv, H., Zhen, C., Liu, J., Yang, P., Hu, L., & Shang, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3150145 · Cited by 320 · see citing works

Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis

Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252 · see citing works

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

Mohell, N., Alfredsson, J., Fransson, Å., Uustalu, M., Byström, S., Gullbo, J., Hallberg, A., Bykov, V. J. N., Björklund, U., & Wiman, K. G. (2015) · Cell Death &amp; Disease · doi:10.1038/cddis.2015.143 · Cited by 183 · see citing works

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy

Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168 · see citing works

The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence

Varesi, A., Chirumbolo, S., Campagnoli, L. I. M., Pierella, E., Piccini, G. B., Carrara, A., Ricevuti, G., Scassellati, C., Bonvicini, C., & Pascale, A. (2022) · Antioxidants · doi:10.3390/antiox11071224 · Cited by 145 · see citing works

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition

Hanssen, K. M., Haber, M., & Fletcher, J. I. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100795 · Cited by 102 · see citing works

Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy

(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71 · see citing works

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant high-grade serous ovarian cancer

Fransson, Å., Glaessgen, D., Alfredsson, J., Wiman, K. G., Bajalica-Lagercrantz, S., & Mohell, N. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0239-6 · Cited by 65 · see citing works

Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by ¹H NMR Based Metabolic Profiling

Xing, Y.-X., Li, M.-H., Tao, L., Ruan, L.-Y., Hong, W., Chen, C., Zhao, W.-L., Xu, H., Chen, J.-F., & Wang, J.-S. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00029 · Cited by 46 · see citing works

Utilization of glutathione during 1,2-dihaloethane metabolism in rat hepatocytes

Jean, P. A., & Reed, D. J. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00027a011 · Cited by 26 · see citing works

Synthesis and transport of glutathione by cultured human retinal pigment epithelial cells.

Davidson, P., Sternberg, P. W., Jones, D., et al. (1994) · PubMed · Cited by 45 · see citing works

Changes in glutathione concentration in hypothermically perfused dog kidneys.

Boudjéma, K., Lindell, S. L., Southard, J. H., et al. (1991) · PubMed · Cited by 8 · see citing works

Glutathione status and sensitivity to GSH-reacting compounds of Escherichia coli strains deficient in glutathione metabolism and/or catalase activity

Alonso-Moraga, Á., Bocanegra, A., Torres, J. M., et al. (1987) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229377 · Cited by 27 · see citing works

穀胱甘肽或/和N－乙醯半胱胺酸的補充對慢性腎功能損傷小鼠的氧化壓力及抗氧化能力的影響

陸晴 (2019) · doi:10.6834/csmu201900121